<DOC>
	<DOCNO>NCT00629304</DOCNO>
	<brief_summary>TELEDIAB-1 national , multicenter , control , randomise trial . The Primary objective TELEDIAB-1 study demonstrate PDA-FIT system ( PDA-Phone and/or telemonitoring ) able improve metabolic control chronically uncontrolled type 1 diabetic patient , despite intensive insulin therapy ( multiple daily injection basal-bolus insulin insulin pump ) , compare conventional care . Main judgment criterion : comparison HbA1c mean 3 group 6 month</brief_summary>
	<brief_title>Multicenter Assessment PDA-FIT System Type 1 Diabetic Patients</brief_title>
	<detailed_description>Secondary Objectives : 1 . To assess improvement blood glucose control quality life patient use PDA-FIT system 2 . To assess improvement diabetes care provide use PDA-FIT system 3 . Satisfaction patient physicians towards PDA-FIT system</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>type 1 diabetes mellitus ≥ 12 month ( include Cpeptide negative secondary diabetes ) age &gt; 18 y.o . intensive insulin basalbolus therapy ≥ 6 month . At inclusion , patient treat , either combination basal , longacting insulin insulin rapid analog meal , rapid insulin analog deliver pump chronically uncontrolled diabetes HbA1c ≥ 8 % past 12 month inclusion patient unstable associate evolutive pathology patient need frequent diabetic follow ( protocol ) patient education teach within 3 month inclusion patient hemoglobinopathy patient toxicomania , alcoholism psychological trouble type 2 diabetes patient patient n't need strict metabolic objective pregnant parturient woman person freedom ( prisoner )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>type 1 diabetes</keyword>
	<keyword>PDA phone ( Personal Digital Assistant )</keyword>
	<keyword>HbA1c</keyword>
</DOC>